Dreger, P., Fenske, T. S., Montoto, S., Pasquini, M. C., Sureda, A., & Hamadani, M. (2020). Cellular immunotherapy for refractory diffuse large B cell lymphoma in the chimeric antigen receptor-engineered T cell era: Still a role for allogeneic transplantation? Biology of blood and marrow transplantation, 26(4), . https://doi.org/10.1016/j.bbmt.2019.12.771
Chicago-Zitierstil (17. Ausg.)Dreger, Peter, Timothy S. Fenske, Silvia Montoto, Marcelo C. Pasquini, Anna Sureda, und Mehdi Hamadani. "Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-engineered T Cell Era: Still a Role for Allogeneic Transplantation?" Biology of Blood and Marrow Transplantation 26, no. 4 (2020). https://doi.org/10.1016/j.bbmt.2019.12.771.
MLA-Zitierstil (9. Ausg.)Dreger, Peter, et al. "Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-engineered T Cell Era: Still a Role for Allogeneic Transplantation?" Biology of Blood and Marrow Transplantation, vol. 26, no. 4, 2020, https://doi.org/10.1016/j.bbmt.2019.12.771.